Prevalence, Risk Factor and Clinical Significance of Hepatitis D Virus Infection Among Targeted High Risk Population in Thailand: Nationwide Survey 2022-2024

Status: Recruiting
Location: See all (4) locations...
Study Type: Observational
SUMMARY

There is very limited data of HDV in Thailand. As both HDV and HIV can accelerate the HBV course and increased the risk of death, particularly, among those with low CD4 cells/count, therefore, HDV burden in this special population is unmet need. Therefore, this study plans to perform a nationwide survey of the prevalence and predictor of HDV among people uses drugs (PWID) with and without HIV, HBV/HIV (MSM vs non MSM), HBV related cirrhosis. Findinds from this study will provide the scientific community to understand how important HDV is among HBV patients, this could be used to develop strategies for HDV screening and treatment

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Male or female, aged 18 years and older

• Chronically-infected with HBV, as defined by:

• Positive Hepatitis B surface antigen HBsAg) or HBV DNA result with a subsequent positive HBsAg or HBV DNA result at least 6 months after first positive result

• Provide signed and dated informed consent form.

Locations
Other Locations
Thailand
HIV-NAT, Thai Red Cross - AIDS Research Centre
RECRUITING
Bangkok
King memorial Chulalongkorn hospital
RECRUITING
Bangkok
Siriraj Hospital, Mahidol University
RECRUITING
Bangkok
Taksin Hospital
RECRUITING
Bangkok
Contact Information
Primary
Chatsuda Auchieng
chatsuda.a@hivnat.org
6626523040
Backup
Pirapon J Ohata, BSc
juneohata4@gmail.com
6626523040
Time Frame
Start Date: 2023-01-30
Estimated Completion Date: 2025-05
Participants
Target number of participants: 3152
Treatments
HDV cohort
Chronic Hepatitis B (HBsAg+) with cirrhosis (APRI \>1.5, FIB-4 \> 3.25, Fibroscan \> 12.5, imaging), PWID with HBV, HIV/HBV, HBV/HCV, aged 18 years and older
Related Therapeutic Areas
Sponsors
Collaborators: King Chulalongkorn Memorial Hospital, Taksin Hospital, Siriraj Hospital, Thai Red Cross AIDS Research Centre, Gilead Sciences
Leads: The HIV Netherlands Australia Thailand Research Collaboration

This content was sourced from clinicaltrials.gov